Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Connection

Marco Del Chiaro to Predictive Value of Tests

This is a "connection" page, showing publications Marco Del Chiaro has written about Predictive Value of Tests.

 
Connection Strength
 
 
 
0.278
 
  1. Crippa S, Fogliati A, Valente R, Sadr-Azodi O, Arnelo U, Capurso G, Halimi A, Partelli S, Ateeb Z, Arcidiacono PG, Lohr JM, Falconi M, Del Chiaro M. A tug-of-war in intraductal papillary mucinous neoplasms management: Comparison between 2017 International and 2018 European guidelines. Dig Liver Dis. 2021 08; 53(8):998-1003.
    View in: PubMed
    Score: 0.123
  2. Del Chiaro M, Segersv?rd R, Lohr M, Verbeke C. Early detection and prevention of pancreatic cancer: is it really possible today? World J Gastroenterol. 2014 Sep 14; 20(34):12118-31.
    View in: PubMed
    Score: 0.078
  3. Schulick AC, Moore HB, Franco SR, Jiang JG, Edil BH, Schulick RD, Nydam TL, McCarter MD, Del Chiaro M, Gleisner A. Gaining a new angle on pancreas cancer: A pre-operative thrombelastographic parameter predicts recurrence and survival among patients with resected periampullary and pancreatic adenocarcinoma. Am J Surg. 2024 Dec; 238:115820.
    View in: PubMed
    Score: 0.038
  4. Jung W, Park T, Kim Y, Park H, Han Y, He J, Wolfgang CL, Blair A, Rashid MF, Kluger MD, Su GH, Chabot JA, Yang CY, Lou W, Valente R, Del Chiaro M, Shyr YM, Wang SE, van Huijgevoort NCM, Besselink MG, Yang Y, Kim H, Kwon W, Kim SW, Jang JY. Validation of a nomogram to predict the risk of cancer in patients with intraductal papillary mucinous neoplasm and main duct dilatation of 10?mm or less. Br J Surg. 2019 12; 106(13):1829-1836.
    View in: PubMed
    Score: 0.027
  5. Giovannetti E, Del Tacca M, Mey V, Funel N, Nannizzi S, Ricci S, Orlandini C, Boggi U, Campani D, Del Chiaro M, Iannopollo M, Bevilacqua G, Mosca F, Danesi R. Transcription analysis of human equilibrative nucleoside transporter-1 predicts survival in pancreas cancer patients treated with gemcitabine. Cancer Res. 2006 Apr 01; 66(7):3928-35.
    View in: PubMed
    Score: 0.011
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)